Citation: | HONG Jing, ZHU Qing, CAI Xintian, LIU Shasha, WU Ting, WANG Guoliang, LI Nanfang. Association of serum MCP-1 levels with vasculitis: A meta-analysis[J]. Chinese Journal of General Practice, 2023, 21(10): 1778-1782. doi: 10.16766/j.cnki.issn.1674-4152.003223 |
[1] |
FELICETTI M, TREPPO E, POSARELLI C, et al. One year in review 2020: vasculitis[J]. Clin Exp Rheumatol, 2020, 124(2): 3-14.
|
[2] |
侯传云, 李志军. 系统性血管炎的诊断与治疗[J]. 中华全科医学, 2020, 18(5): 710-711. http://www.zhqkyx.net/article/id/450159ed-8208-42b3-bea4-23f0ad841586
HOU C Y, LI Z J. Diagnosis and treatment of systemic vasculitis[J]. Chinese Journal of General Practice, 2020, 18(5): 710-711. http://www.zhqkyx.net/article/id/450159ed-8208-42b3-bea4-23f0ad841586
|
[3] |
ZHU Q, LIU S S, HEIZHATI M, et al. Systemic vasculitis: an important and underestimated cause of malignant hypertension[J]. Cardiovasc Innov Appl, 2019, 4(2): 99-108.
|
[4] |
JENNETTE J C, FALK R J, BACON P A, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11. doi: 10.1002/art.37715
|
[5] |
LIU S S, LI N F, ZHU Q, et al. Increased serum MCP-1 levels in systemic vasculitis patients with renal involvement[J]. J Interferon Cytokine Res, 2018, 38(9): 406-412. doi: 10.1089/jir.2017.0140
|
[6] |
DESHMANE S L, KREMLEV S, AMINI S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview[J]. J Interferon Cytokine Res, 2009, 29(6): 313-326. doi: 10.1089/jir.2008.0027
|
[7] |
HALLER H, BERTRAM A, NADROWITZ F, et al. Monocyte chemoattractant protein-1 and the kidney[J]. Curr Opin Nephrol Hypertens, 2016, 25(1): 42-49. doi: 10.1097/MNH.0000000000000186
|
[8] |
CID M C, HOFFMAN M P, HERNÁNDEZ-RODRÍGUEZ J, et al. Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis[J]. Rheumatology (Oxford), 2006, 45(11): 1356-1363. doi: 10.1093/rheumatology/kel128
|
[9] |
ELLINGSEN T, ELLING P, OLSON A, et al. Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica[J]. Ann Rheum Dis, 2000, 59(10): 775-780. doi: 10.1136/ard.59.10.775
|
[10] |
张铭明, 张锐, 杨小珂, 等. 抗中性粒细胞胞浆抗体相关性血管炎患者中MIF及MCP-1的检测及临床意义[J]. 国际检验医学杂志, 2020, 41(13): 1581-1584. doi: 10.3969/j.issn.1673-4130.2020.13.011
ZHANG M M, ZHANG R, YANG X K, et al. The study of MIF and MCP-1 in patients with anti-neutrophil cytoplasmic antibody associated vasculitis[J]. International Journal of Laboratory Medicine, 2020, 41(13): 1581-1584. doi: 10.3969/j.issn.1673-4130.2020.13.011
|
[11] |
MIRIOGLU S, CINAR S, YAZICI H, et al. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus[J]. Lupus, 2020, 29(4): 379-388. doi: 10.1177/0961203320904997
|
[12] |
SUZUKI K, NAGAO T, ITABASHI M, et al. A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis[J]. Nephrol Dial Transplant, 2014, 29(6): 1168-1177. doi: 10.1093/ndt/gft469
|
[13] |
OZER H T, ERKEN E, GUNESACAR R, et al. Serum RANTES, MIP-1alpha, and MCP-1 levels in Behet ' s disease[J]. Rheumatol Int, 2005, 25(6): 487-488. doi: 10.1007/s00296-004-0519-0
|
[14] |
KABURAKI T, FUJINO Y, KAWASHIMA H, et al. Plasma and whole-blood chemokine levels in patients with Behcet ' s disease[J]. Graefes Arch Clin Exp Ophthalmol, 2003, 241(5): 353-358. doi: 10.1007/s00417-003-0668-y
|
[15] |
ANTONELLI A, FALLAHI P, FERRARI S M, et al. Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2[J]. Clin Rheumatol, 2013, 32(8): 1147-1154. doi: 10.1007/s10067-013-2246-y
|
[16] |
ANTONELLI A, FERRI C, FALLAHI P, et al. CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C[J]. Dig Liver Dis, 2009, 41(1): 42-48. doi: 10.1016/j.dld.2008.04.009
|
[17] |
孙伟娜, 陈院朝, 蔡文杰. 45例系统性血管炎患者炎症性因子检测结果分析[J]. 中外健康文摘, 2013, 10(28): 158.
SUN W N, CHEN Y C, CAI W J. Analysis of inflammatory factors in 45 patients with systemic vasculitis[J]. World Health Digest Medical Periodieal, 2013, 10(28): 158.
|
[18] |
DHAWAN V, MAHAJAN N, JAIN S. Role of C-C chemokines in Takayasu ' s arteritis disease[J]. Int J Cardiol, 2006, 112(1): 105-111. doi: 10.1016/j.ijcard.2005.11.101
|
[19] |
WALLACE G R, FARMER I, CHURCH A, et al. Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis[J]. Immunol Lett, 2003, 90(1): 59-64. doi: 10.1016/S0165-2478(03)00159-7
|
[20] |
朱晴, 朱彬, 吴婷, 等. 高迁移率族蛋白水平与系统性血管炎相关性的Meta分析[J]. 中华全科医学, 2021, 19(1): 131-136. doi: 10.16766/j.cnki.issn.1674-4152.001749
ZHU Q, ZHU B, WU T, et al. Meta-analysis of the relationship between HMGB1 level and systemic vasculitis[J]. Chinese Journal of General Practice, 2021, 19(1): 131-136. doi: 10.16766/j.cnki.issn.1674-4152.001749
|
[21] |
NORRIS J M, SIMPSON B S, BALLR, et al. A modified Newcastle-Ottawa scale for assessment of study quality in genetic urological research[J]. Eur Urol, 2021, 79(3): 325-326.
|
[22] |
SUGIYAMA M, WADA Y, KANAZAWA N, et al. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy[J]. PLoS One, 2020, 15(4): e0232194. DOI: 10.1371/journal.pone.0232194.
|
[23] |
TAM F W, SANDERS J S, GEORGE A, et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis[J]. Nephrol Dial Transplant, 2004, 19(11): 2761-2768.
|
[24] |
MORAN S M, MONACH P A, ZGAGA L, et al. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis[J]. Nephrol Dial Transplant, 2020, 35(2): 283-291.
|